Pivotal role of orexin signaling in the posterior paraventricular nucleus of the thalamus during the stress-induced reinstatement of oxycodone-seeking behavior
- PMID: 38888086
- PMCID: PMC11407285
- DOI: 10.1177/02698811241260989
Pivotal role of orexin signaling in the posterior paraventricular nucleus of the thalamus during the stress-induced reinstatement of oxycodone-seeking behavior
Abstract
Background: The orexin (OX) system has received increasing interest as a potential target for treating substance use disorder. OX transmission in the posterior paraventricular nucleus of the thalamus (pPVT), an area activated by highly salient stimuli that are both reinforcing and aversive, mediates cue- and stress-induced reinstatement of reward-seeking behavior. Oral administration of suvorexant (SUV), a dual OX receptor (OXR) antagonist (DORA), selectively reduced conditioned reinstatement of oxycodone-seeking behavior and stress-induced reinstatement of alcohol-seeking behavior in dependent rats.
Aims: This study tested whether OXR blockade in the pPVT with SUV reduces oxycodone or sweetened condensed milk (SCM) seeking elicited by conditioned cues or stress.
Methods: Male Wistar rats were trained to self-administer oxycodone (0.15 mg/kg, i.v., 8 h/day) or SCM (0.1 ml, 2:1 dilution [v/v], 30 min/day). After extinction, we tested the ability of intra-pPVT SUV (15 µg/0.5 µl) to prevent reinstatement of oxycodone or SCM seeking elicited by conditioned cues or footshock stress.
Results: The rats acquired oxycodone and SCM self-administration, and oxycodone intake correlated with signs of physical opioid withdrawal, confirming dependence. Following extinction, the presentation of conditioned cues or footshock elicited reinstatement of oxycodone- and SCM-seeking behavior. Intra-pPVT SUV blocked stress-induced reinstatement of oxycodone seeking but not conditioned reinstatement of oxycodone or SCM seeking or stress-induced reinstatement of SCM seeking.
Conclusions: The results indicate that OXR signaling in the pPVT is critical for stress-induced reinstatement of oxycodone seeking, further corroborating OXRs as treatment targets for opioid use disorder.
Keywords: Orexin; conditioned reinstatement; paraventricular nucleus of the thalamus; prescription opioid; stress-induced reinstatement.
Conflict of interest statement
Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures








Similar articles
-
Targeting the orexin system for prescription opioid use disorder: Orexin-1 receptor blockade prevents oxycodone taking and seeking in rats.Neuropharmacology. 2020 Mar 1;164:107906. doi: 10.1016/j.neuropharm.2019.107906. Epub 2019 Dec 4. Neuropharmacology. 2020. PMID: 31841797 Free PMC article.
-
ADX106772, an mGlu2 receptor positive allosteric modulator, selectively attenuates oxycodone taking and seeking.Neuropharmacology. 2023 Nov 1;238:109666. doi: 10.1016/j.neuropharm.2023.109666. Epub 2023 Jul 16. Neuropharmacology. 2023. PMID: 37463637 Free PMC article.
-
Daily treatment with the dual orexin receptor antagonist DORA-12 during oxycodone abstinence decreases oxycodone conditioned reinstatement.Neuropharmacology. 2023 Nov 15;239:109685. doi: 10.1016/j.neuropharm.2023.109685. Epub 2023 Aug 12. Neuropharmacology. 2023. PMID: 37579870 Free PMC article.
-
Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.Cochrane Database Syst Rev. 2018 Jun 5;6(6):CD006332. doi: 10.1002/14651858.CD006332.pub3. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2022 Sep 15;9:CD006332. doi: 10.1002/14651858.CD006332.pub4. PMID: 29869799 Free PMC article. Updated.
-
Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.Cochrane Database Syst Rev. 2022 Sep 15;9(9):CD006332. doi: 10.1002/14651858.CD006332.pub4. Cochrane Database Syst Rev. 2022. PMID: 36106667 Free PMC article.
Cited by
-
Motivating Effects of Negative-hedonic Valence Encoded in Engrams.Res Sq [Preprint]. 2025 Feb 27:rs.3.rs-5708632. doi: 10.21203/rs.3.rs-5708632/v1. Res Sq. 2025. PMID: 40060046 Free PMC article. Preprint.
-
Orexin receptors: possible therapeutic targets for psychiatric disorders.Psychopharmacology (Berl). 2025 Aug;242(8):1669-1691. doi: 10.1007/s00213-025-06767-1. Epub 2025 Mar 28. Psychopharmacology (Berl). 2025. PMID: 40153060 Review.
-
Escalated Oxycodone Self-Administration Is Associated with Activation of Specific Gene Networks in the Rat Dorsal Striatum.Int J Mol Sci. 2025 Jul 30;26(15):7356. doi: 10.3390/ijms26157356. Int J Mol Sci. 2025. PMID: 40806484 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical